Dechra Pharmaceutical

Pharma

Dechra continues growth spurt with $41M acquisition of Apex

The U.K.’s Dechra Pharmaceuticals has been on an acquisition binge over the last year. Now it’s expanding its geographic footprint even further, picking up Australia’s Apex Laboratories for AU$55 million ($41.2 million).

Arlene Weintraub Sep 16, 2016 2:33pm

Dechra charts strong growth with new drug approvals and global expansion

Feb 22, 2016 8:37am